Parker, Alexander S <br/><br/>
Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.  [electronic resource] 

 -  European urology  Nov 2014 
 - 929-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural; Validation Study 
<br/><br/><label>ISSN: </label>1873-7560 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2013.12.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antigens, Neoplasm--analysis<br/>Biomarkers, Tumor--analysis<br/>Biopsy<br/>Carcinoma, Renal Cell--enzymology<br/>DNA Topoisomerases, Type II--analysis<br/>DNA-Binding Proteins--analysis<br/>Female<br/>Florida<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Kidney Neoplasms--enzymology<br/>Male<br/>Middle Aged<br/>Minnesota<br/>Multivariate Analysis<br/>Necrosis<br/>Neoplasm Grading<br/>Neoplasm Staging<br/>Nephrectomy--adverse effects<br/>Observer Variation<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Registries<br/>Reproducibility of Results<br/>Risk Assessment<br/>Risk Factors<br/>Tertiary Care Centers<br/>Time Factors<br/>Treatment Outcome<br/>Tumor Burden<br/>Up-Regulation<br/>Young Adult